HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using Human Dermal Fibroblasts (HDFs), today announced the preliminary results of Phase II Animal Studies for Spinal Disc Height Improvement. The study began in 2014 with Rush University and Howard An, M.D., The Morton International Endowed Chair Professor […]